Ionis Pharmaceuticals Inc

NASDAQ:IONS   4:00:00 PM EDT
40.79
+2.03 (+5.24%)
5:05:02 PM EDT: $40.79 0.00 (0.00%)
Other Pre-Announcement

Ionis Reports Third Quarter Financial Results

Published: 11/09/2022 12:36 GMT
Ionis Pharmaceuticals Inc (IONS) - Ionis Reports Third Quarter Financial Results.
Increased 2022 Cash and Investments Guidance.
Qtrly Total Revenue $160 Million Versus $133 Million.
Reaffirmed Its Full Year 2022 Guidance for Total Revenue, Operating Expenses and Net Loss, on a Non-GAAP Basis.
Expects to Recognize a Substantial Gain on Sale of Its Real Estate Assets in Q4.
Increased Its Full Year 2022 Cash and Investments Guidance to Approximately $2.0 Billion From Previous Guidance of $1.7 Billion.
Qtrly Loss per Share $0.33.
Q3 Earnings per Share View $-0.74, Revenue View $143.9 Million -- Refinitiv Ibes Data (analyst estimates).
FY2022 Earnings per Share View $-2.70, Revenue View $594.5 Million -- Refinitiv Ibes Data (analyst estimates).